GlassScriptPhysician profile
Alexander I Kraev
NPI 1841444197
$4,705.57
in general payments reported to CMS, 2019-2025
11 companies · $493 in 2025
The $493 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.88 · 2020: $2,381 · 2021: $1,330 · 2022: $121 · 2024: $319 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biostable Science & Engineering | $3,400.00 | 2020-2021 | |
| Medtronic, INC. | $446.53 | 2021-2025 | Corevalve Evolut R |
| Artivion, INC. | $276.68 | 2020-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical |
| Abbott Laboratories | $203.32 | 2025 | Epic |
| Edwards Lifesciences Corporation | $96.00 | 2025 | Sapien 3 Ultra Resilia |
| Baxter Healthcare | $67.25 | 2020 | |
| Medtronic Vascular, INC. | $60.88 | 2019 | |
| Abiomed | $58.68 | 2021-2024 | Impella |
| Atricure, INC. | $52.77 | 2024 | |
| Solventum Corporation | $21.98 | 2024 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
| Becton, Dickinson and Company | $21.48 | 2025 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Kraev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.